awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q43218254-E4DDB3AF-4D22-492A-8A87-33A1658E3079
Q43218254-E4DDB3AF-4D22-492A-8A87-33A1658E3079
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43218254-E4DDB3AF-4D22-492A-8A87-33A1658E3079
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
P2860
Q43218254-E4DDB3AF-4D22-492A-8A87-33A1658E3079
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43218254-E4DDB3AF-4D22-492A-8A87-33A1658E3079
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cdc55dd009bbf5115818fe978db64cd75e5dfbb2
P2860
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol